Australian Clinical Labs Management
Management criteria checks 4/4
Australian Clinical Labs' CEO is Melinda McGrath, appointed in Dec 2020, has a tenure of 3.33 years. total yearly compensation is A$1.18M, comprised of 74.2% salary and 25.8% bonuses, including company stock and options. directly owns 1.46% of the company’s shares, worth A$7.10M. The average tenure of the management team and the board of directors is 8.3 years and 3 years respectively.
Key information
Melinda McGrath
Chief executive officer
AU$1.2m
Total compensation
| CEO salary percentage | 74.2% |
| CEO tenure | 3.3yrs |
| CEO ownership | 1.5% |
| Management average tenure | 8.3yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?
Feb 21
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?
Dec 08Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today
Aug 14Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)
Dec 22The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More
Dec 21The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business
Sep 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | AU$15m |
| Sep 30 2023 | n/a | n/a | AU$26m |
| Jun 30 2023 | AU$1m | AU$873k | AU$36m |
| Mar 31 2023 | n/a | n/a | AU$55m |
| Dec 31 2022 | n/a | n/a | AU$73m |
| Sep 30 2022 | n/a | n/a | AU$126m |
| Jun 30 2022 | AU$2m | AU$873k | AU$178m |
| Mar 31 2022 | n/a | n/a | AU$156m |
| Dec 31 2021 | n/a | n/a | AU$134m |
| Sep 30 2021 | n/a | n/a | AU$97m |
| Jun 30 2021 | AU$2m | AU$875k | AU$60m |
| Mar 31 2021 | n/a | n/a | AU$79m |
| Dec 31 2020 | n/a | n/a | AU$98m |
| Sep 30 2020 | n/a | n/a | AU$70m |
| Jun 30 2020 | AU$2m | AU$852k | AU$41m |
Compensation vs Market: Melinda's total compensation ($USD754.01K) is about average for companies of similar size in the Australian market ($USD752.00K).
Compensation vs Earnings: Melinda's compensation has been consistent with company performance over the past year.
CEO
Melinda McGrath
3.3yrs
Tenure
AU$1,175,644
Compensation
Ms. Melinda McGrath is Chief Executive Officer and Executive Director at Australian Clinical Labs Limited since December 19, 2020. She served as Chief Executive Officer and Executive Director at Clinical L...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.3yrs | AU$1.18m | 1.46% A$ 7.1m | |
| Chief Financial Officer | 13.2yrs | AU$615.76k | 0.13% A$ 611.1k | |
| Chief Operating Officer | 8.3yrs | no data | 0.38% A$ 1.8m | |
| Chief Information Officer | 9.3yrs | no data | no data | |
| National Marketing Director | no data | no data | no data | |
| National Medical Director & Chief Pathologist | 15.3yrs | no data | 0.42% A$ 2.0m | |
| Chief Executive Officer of New South Wales & Australian Capital Territory | 13.3yrs | no data | no data | |
| Chief Executive Officer of Western Australia | 6.3yrs | no data | no data | |
| Chief Executive Officer of South Australia & Northern Territory | 9.3yrs | no data | no data | |
| Company Secretary | 3yrs | no data | no data | |
| Chief Executive Officer of ACL Commercial Pathology | 1.3yrs | no data | no data | |
| Chief Executive Officer of Victoria | 1.3yrs | no data | no data |
8.3yrs
Average Tenure
Experienced Management: ACL's management team is seasoned and experienced (8.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.3yrs | AU$1.18m | 1.46% A$ 7.1m | |
| Non-Executive Chairman | less than a year | AU$190.00k | 0.14% A$ 681.6k | |
| Independent Non-Executive Director | less than a year | no data | 0.010% A$ 48.6k | |
| Independent Non-Executive Director | 3yrs | AU$145.66k | 0.041% A$ 199.0k | |
| Non Executive Director | 3.3yrs | AU$130.00k | no data | |
| Independent Non-Executive Director | 3yrs | AU$140.64k | 0.0025% A$ 12.1k | |
| Independent Non-Executive Director | 3yrs | AU$145.66k | 0.024% A$ 115.4k |
3.0yrs
Average Tenure
63yo
Average Age
Experienced Board: ACL's board of directors are considered experienced (3 years average tenure).